ASRS
GLUE icon

Arizona State Retirement System’s Monte Rosa Therapeutics GLUE Stock Holding History

Arizona State Retirement System’s Portfolio GLUE Stock Details GLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$321K Buy
+13,247
New +$250K ﹤0.01% 1769
2023
Q4 		– Sell
-11,951
Closed -$57.2K – 2169
2023
Q3 		$57.2K Buy
11,951
+166
+1% +$1.07K ﹤0.01% 2139
2023
Q2 		$80.7K Buy
+11,785
New +$76.2K ﹤0.01% 2144

Other funds holding GLUE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Arizona State Retirement System's GLUE Position: Q2 2026 in Review

Arizona State Retirement System opened a new position in Monte Rosa Therapeutics (GLUE) in Q2 2026: 13,247 shares worth $321K. The stake represents ﹤0.01% of the portfolio and ranks #1769 among its holdings. This is a return to the name: Arizona State Retirement System previously reported a position in GLUE as recently as Q3 2023.

Arizona State Retirement System first reported a position in GLUE in Q2 2023 and has held it in 3 quarters since. 193 funds tracked by Wall St. Rank hold GLUE as of Q2 2026.

  • Arizona State Retirement System held 13,247 shares of Monte Rosa Therapeutics worth $321K as of Q2 2026.
  • Monte Rosa Therapeutics was a new Arizona State Retirement System position in Q2 2026.
  • Monte Rosa Therapeutics made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1769 holding.
  • Arizona State Retirement System first reported a position in Monte Rosa Therapeutics in Q2 2023 and has held it in 3 quarters since.
  • 193 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.